Autonomix Medical, Inc. Common Stock Total Assets
Autonomix Medical, Inc. Common Stock total assets. Based on the latest financial reports, Autonomix Medical, Inc. Common Stock (AMIX) holds total assets worth $3.98 Million USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Autonomix Medical, Inc. Common Stock stock valuation for the company's overall valuation and market capitalisation.
Total Assets of Autonomix Medical, Inc. Common Stock (2022–2026)
Total assets of Autonomix Medical, Inc. Common Stock from 2022 to 2026. This chart illustrates how Autonomix Medical, Inc. Common Stock's total assets have evolved over time, based on quarterly financial data. See latest Autonomix Medical, Inc. Common Stock stock price today for real-time trading data and today's change.
Autonomix Medical, Inc. Common Stock - Asset Composition Analysis
Autonomix Medical, Inc. Common Stock Total Assets Breakdown (March 2026)
Autonomix Medical, Inc. Common Stock total assets breakdown as of March 2026. Autonomix Medical, Inc. Common Stock's total assets of $3.98 Million consist of 99.8% current assets and 0.3% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 92.2% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2022–2026)
This chart illustrates how Autonomix Medical, Inc. Common Stock's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore AMIX working capital efficiency to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Autonomix Medical, Inc. Common Stock's current assets represent 99.8% of total assets in 2026, a decrease from 100.0% in 2022.
- Cash Position: Cash and equivalents constituted 92.2% of total assets in 2026, down from 99.6% in 2022.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2022.
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
Autonomix Medical, Inc. Common Stock Competitors by Total Assets
Key competitors of Autonomix Medical, Inc. Common Stock based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $96.98 Million |
|
Medtronic plc
SA:MDTC34
|
Brazil | R$93.03 Billion |
|
COCHLEAR LTD ADR 1/2/O.N.
F:OC50
|
Germany | €2.83 Billion |
|
Vitrolife AB
ST:VITR
|
Sweden | Skr11.30 Billion |
|
Medartis Holding AG
SW:MED
|
Switzerland | CHF610.05 Million |
|
Shanghai Kinetic Medical Co
SHE:300326
|
China | CN¥3.38 Billion |
|
Shanghai Sanyou Medical Co Ltd
SHG:688085
|
China | CN¥2.34 Billion |
|
TAIDOC TECHNOLOGY CORP
TW:4736
|
Taiwan | NT$13.07 Billion |
Autonomix Medical, Inc. Common Stock - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.85 | 4.57 | 3.91 |
| Quick Ratio | 4.85 | 4.57 | 3.91 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $3.15 Million | $7.01 Million | $644.00K |
Autonomix Medical, Inc. Common Stock - Advanced Valuation Insights
This section examines the relationship between Autonomix Medical, Inc. Common Stock's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.40 |
| Latest Market Cap to Assets Ratio | 0.19 |
| Asset Growth Rate (YoY) | -22.5% |
| Total Assets | $7.60 Million |
| Market Capitalization | $1.48 Million USD |
Valuation Analysis
Below Book Valuation: The market values Autonomix Medical, Inc. Common Stock's assets below their book value (0.19x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Autonomix Medical, Inc. Common Stock's assets decreased by 22.5% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Autonomix Medical, Inc. Common Stock (2022–2026)
The table below shows the annual total assets of Autonomix Medical, Inc. Common Stock from 2022 to 2026.
| Year | Total Assets | Change |
|---|---|---|
| 2026-03-31 | $7.60 Million | -22.50% |
| 2025-03-31 | $9.81 Million | +4.24% |
| 2024-03-31 | $9.41 Million | +987.51% |
| 2023-03-31 | $865.00K | -57.86% |
| 2022-03-31 | $2.05 Million | -- |
About Autonomix Medical, Inc. Common Stock
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders of nervous system. The company's technology platform includes a catheter-based system incorporating microchip-enabled sensing architecture designed to detect low-amplitude neural signals from within the vascular system. It develops technology for patients with … Read more